Vitrolife
137.00 SEK
-3.04 %
Less than 1K followers
VITR
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
-3.04 %
-1.30 %
+0.07 %
-12.96 %
-36.28 %
-36.98 %
-27.74 %
-34.32 %
+2,132.36 %
Vitrolife is an international group that provides medical devices and genetic services. The company develops and manufactures services and products for personalized genetic information as well as medical devices in the field of fertility. Vitrolife supports customers in their operations to improve patient outcomes from fertility treatments. Vitrolife's products and services are available globally. The company is headquartered in Gothenburg, Sweden.
Read moreMarket cap
18.56B SEK
Turnover
17M SEK
Revenue
3.61B
EBIT %
21.7 %
P/E
36.15
Dividend yield-%
0.8 %
Revenue and EBIT-%
Revenue B
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
3.2
2026
Annual report '25
23.4
2026
Interim report Q1'26
6.5
2026
General meeting '26
All
Webcasts
Press releases
3rd party
ShowingAll content types
Vitrolife, Audiocast, Q3'25
Vitrolife AB (publ): Interim report Q3, 2025: Strong growth in Americas
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
